Literature DB >> 10579225

Mu and kappa1 opioid-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in cynomolgus monkey brain.

L J Sim-Selley1, J B Daunais, L J Porrino, S R Childers.   

Abstract

Agonist-stimulated [35S]GTPgammaS binding allows the visualization of receptor-activated G-proteins, thus revealing the anatomical localization of functional receptor activity. In the present study, agonist-stimulated [35S]GTPgammaS binding was used to demonstrate mu and kappa1 opioid-stimulated [35S]GTPgammaS binding in tissue sections and membranes from cynomolgus monkey brain using DAMGO and U50,488H, respectively. Concentrations of agonists required to produce maximal stimulation of [35S]GTPgammaS binding were determined in membranes from the frontal poles of the brain. Receptor specificity was verified in both membranes and sections by inhibiting agonist-stimulated [35S]GTPgammaS binding with the appropriate antagonist. Mu opioid-stimulated [35S]GTPgammaS binding was high in areas including the amygdala, ventral striatum, caudate, putamen, medial thalamus and hypothalamus. Dense mu-stimulated [35S]GTPgammaS binding was also found in brainstem nuclei including the interpeduncular nucleus, parabrachial nucleus and nucleus of the solitary tract. Kappa1 opioid-stimulated [35S]GTPgammaS binding was high in limbic and association cortex, ventral striatum, caudate, putamen, globus pallidus, claustrum, amygdala, hypothalamus and substantia nigra. These results demonstrate the applicability of [35S]GTPgammaS autoradiography to examine receptor-activated G-proteins in the primate brain and reveal functional mu and kappa1 opioid receptor activity that may contribute to the reported central nervous system effects of opiates.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579225     DOI: 10.1016/s0306-4522(99)00344-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  22 in total

1.  Effects of butorphanol on morphine-induced itch and analgesia in primates.

Authors:  Heeseung Lee; Norah N Naughton; James H Woods; Mei-Chuan Ko
Journal:  Anesthesiology       Date:  2007-09       Impact factor: 7.892

2.  μ and κ opioid receptor distribution in the monogamous titi monkey (Callicebus cupreus): implications for social behavior and endocrine functioning.

Authors:  B J Ragen; S M Freeman; S A Laredo; S P Mendoza; K L Bales
Journal:  Neuroscience       Date:  2015-01-29       Impact factor: 3.590

3.  Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.

Authors:  Mohini Ranganathan; Ashley Schnakenberg; Patrick D Skosnik; Bruce M Cohen; Brian Pittman; R Andrew Sewell; Deepak Cyril D'Souza
Journal:  Biol Psychiatry       Date:  2012-07-18       Impact factor: 13.382

4.  Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates.

Authors:  H Ding; K Hayashida; T Suto; D D Sukhtankar; M Kimura; V Mendenhall; M C Ko
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

Review 5.  Animal models of substance abuse and addiction: implications for science, animal welfare, and society.

Authors:  Wendy J Lynch; Katherine L Nicholson; Mario E Dance; Richard W Morgan; Patricia L Foley
Journal:  Comp Med       Date:  2010-06       Impact factor: 0.982

6.  Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics.

Authors:  Songye Li; Ming-Qiang Zheng; Mika Naganawa; Sujin Kim; Hong Gao; Michael Kapinos; David Labaree; Yiyun Huang
Journal:  J Nucl Med       Date:  2019-01-10       Impact factor: 10.057

7.  Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys.

Authors:  M C H Ko; K J Willmont; H Lee; G S Flory; J H Woods
Journal:  Brain Res       Date:  2003-08-22       Impact factor: 3.252

8.  A method for conducting functional MRI studies in alert nonhuman primates: initial results with opioid agonists in male cynomolgus monkeys.

Authors:  Marc J Kaufman; Amy C Janes; Blaise deB Frederick; Melanie Brimson-Théberge; Yunjie Tong; Samuel B McWilliams; Ashley Bear; Timothy E Gillis; Katrina M Schrode; Perry F Renshaw; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2013-06-17       Impact factor: 3.157

9.  Determination of the in vivo selectivity of a new κ-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey.

Authors:  Su Jin Kim; Ming-Qiang Zheng; Nabeel Nabulsi; David Labaree; Jim Ropchan; Soheila Najafzadeh; Richard E Carson; Yiyun Huang; Evan D Morris
Journal:  J Nucl Med       Date:  2013-08-05       Impact factor: 10.057

10.  Approaches to Assess Functional Selectivity in GPCRs: Evaluating G Protein Signaling in an Endogenous Environment.

Authors:  Laura M Bohn; Lei Zhou; Jo-Hao Ho
Journal:  Methods Mol Biol       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.